Inovio Pharmaceuticals
INO
#8784
Rank
NZ$0.27 B
Marketcap
NZ$3.96
Share price
-3.80%
Change (1 day)
20.45%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$5.00. In 2024 the company made an earnings per share (EPS) of NZ-$6.86 an increase over its 2023 EPS that were of NZ-$10.58.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-29.97%
2024NZ-$6.86-35.14%
2023NZ-$10.58-56.62%
2022NZ-$24.38-19.54%
2021NZ-$30.3135.9%
2020NZ-$22.30-11.57%
2019NZ-$25.2215.24%
2018NZ-$21.88-2.78%
2017NZ-$22.516.93%
2016NZ-$21.05134.88%
2015NZ-$8.96-29.51%
2014NZ-$12.71-57.34%
2013NZ-$29.80146.55%
2012NZ-$12.0920.83%
2011NZ-$10.00-29.41%
2010NZ-$14.17-48.48%
2009NZ-$27.5110%
2008NZ-$25.0111.11%
2007NZ-$22.51-41.3%
2006NZ-$38.35-66.91%
2005NZ-$115.87110.61%
2004NZ-$55.02-61.63%
2003NZ-$143.38186.67%
2002NZ-$50.02
2001N/A-100%
2000NZ-$40.01-63.64%
1999NZ-$110.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.99-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.13-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ-$2.17-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.78-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$13.19-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.25-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$11.32-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA